object
assess
util
neutrophil
lymphocyt
nlr
lymphocyt
monocyt
lmr
platelet
lymphocyt
ratio
plr
infect
biomark
method
pubmedmedlin
embas
cochran
databas
search
identifi
elig
articl
studi
diagnosi
sever
outcom
includ
prospero
systemat
review
registr
result
forti
studi
includ
report
bacteri
viral
infect
malaria
critic
ill
due
sepsi
ten
studi
report
associ
higher
nlr
bacteraemia
support
metaanalysi
patientlevel
data
five
studi
n
auc
p
identifi
cutoff
two
studi
report
associ
lower
lmr
diagnosi
influenza
viru
infect
patient
respiratori
tract
infect
metaanalysi
patientlevel
data
n
auc
p
identifi
cutoff
direction
associ
nlr
outcom
heterogen
cohort
critic
ill
adult
sepsi
vari
potenti
clinic
util
also
demonstr
pneumonia
nlr
pertussi
nlr
urinari
tract
infect
nlr
diabet
foot
infect
nlr
crimean
congo
haemorrhag
fever
plr
longitudin
measur
lmr
respiratori
viru
infect
reflect
symptom
nlr
sepsi
bacteraemia
predict
mortal
conclus
peripher
blood
leucocyt
ratio
use
infect
biomark
evid
relat
diagnosi
bacteraemia
influenza
viru
infect
critic
ill
due
sepsi
signal
toward
associ
nlr
outcom
exist
nlr
evalu
futur
stratif
model
longitudin
measur
ratio
infect
could
inform
overal
biomark
warrant
recognit
studi
infecti
diseas
infect
biomark
use
adjunct
inform
differenti
diagnosi
eg
distinguish
bacteri
viral
infect
prognost
marker
stratifi
patient
subgroup
endotyp
monitor
respons
antimicrobi
therapi
guid
durat
canon
biomark
includ
total
white
cell
count
wcc
creactiv
protein
crp
ten
year
increas
interest
use
procalcitonin
biomark
discrimin
bacteri
viral
infect
assess
respons
antimicrobi
therapi
metaanalys
clinic
trial
indic
procalcitonin
result
reduc
antimicrobi
usag
improv
outcom
respiratori
tract
infect
similar
find
critic
ill
patient
presum
bacteri
sepsi
intens
care
unit
icu
howev
procalcitonin
measur
current
expens
univers
avail
contrast
full
blood
count
cheap
fast
ubiquit
laboratori
investig
autom
counter
provid
differenti
wcc
enumer
circul
leucocyt
includ
neutrophil
lymphocyt
monocyt
paramet
usual
interpret
isol
sepsi
apoptosi
bcell
tcell
caus
lymphocyt
deplet
peripher
blood
lymphopenia
associ
mortal
nosocomi
infect
lymphopenia
also
associ
presenc
bacteraemia
better
predictor
neutrophil
total
wcc
peripher
blood
neutrophilia
sepsi
involv
demargin
enhanc
marrow
recruit
combin
system
neutrophil
activ
contribut
inflammatori
tissu
damag
organ
failur
therefor
biolog
plausibl
neutrophil
lymphocyt
ratio
nlr
leucocyt
ratio
could
inform
biomark
patient
infect
reflect
underli
immun
dy
function
least
peripher
blood
readi
avail
low
cost
indic
would
make
particularli
help
lowand
middleincom
countri
set
patient
stratif
identifi
requir
higher
level
care
discrimin
bacterialnonbacteri
infect
aid
antimicrobi
stewardship
would
especi
valuabl
paper
systemat
review
literatur
evalu
diagnost
prognost
util
nlr
peripher
blood
leucocyt
ratio
lymphocyt
monocyt
platelet
lymphocyt
ratio
lmr
plr
respect
patient
infect
prisma
statement
follow
conduct
report
systemat
review
protocol
regist
prospero
intern
prospect
regist
systemat
review
avail
http
wwwcrdyorkacukprosperodisplay
recordphp
briefli
follow
key
word
use
search
pubmedmedlin
embas
cochran
databas
june
monocyt
lymphocyt
neutrophil
platelet
ratio
infect
sepsi
bacteraemia
includ
observ
studi
clinic
trial
ratio
measur
peripher
blood
human
age
viral
bacteri
parasit
infect
case
report
confer
abstract
review
articl
exclud
accept
clinic
microbiolog
diagnos
infect
distinguish
evid
system
inflamm
alon
eg
elev
crp
presenc
system
inflammatori
respons
syndrom
sir
alon
insuffici
type
infect
report
syndrom
organ
system
involv
organ
ratio
quantifi
numer
includ
studi
report
follow
data
diagnosi
infect
compar
healthi
control
noninfecti
diagnosi
altern
infect
sever
infect
measur
outcom
infect
measur
due
possibl
confound
effect
ratio
exclud
studi
conduct
exclus
patient
activ
cancer
chronic
liver
diseas
includ
hbv
hcv
infect
hiv
immunosuppress
exclud
studi
use
nonroutin
laboratori
techniqu
quantifi
peripher
blood
cell
count
diagnos
infect
specif
investig
use
pcr
bacteri
diagnosi
exclud
individu
age
includ
result
present
refer
adult
unless
otherwis
state
titleabstract
return
databas
search
fig
review
two
author
cdr
hjg
independ
assess
need
full
text
review
full
text
articl
review
independ
two
author
assess
elig
reason
exclus
record
data
extract
proforma
construct
iter
modifi
use
extract
data
includ
studi
two
author
cdr
ap
risk
bia
patient
select
outcom
report
assess
supplementari
fig
synthesi
result
note
studi
report
one
ratio
bacteraemia
report
separ
studi
includ
addit
categori
relev
therefor
total
exce
ratio
investig
patient
infecti
diseas
shown
bold
consid
demonstr
potenti
clinic
util
cchf
crimean
congo
haemorrhag
fever
narr
addit
metaanalysi
patientlevel
data
relev
studi
provid
author
request
statist
analys
perform
use
graphpad
prism
version
infecti
diseas
leucocyt
ratio
report
includ
studi
shown
fig
nlr
examin
retrospect
patient
sever
sepsi
septic
shock
defin
use
criteria
patient
exclud
termin
malign
previou
resuscit
order
declin
invas
procedur
common
site
infect
lung
intraabdomin
urinari
tract
patient
initi
stratifi
nlr
quintil
ascend
quintil
overal
median
initi
nlr
quintil
quintil
higher
quintil
hypertens
diabet
overrepres
wherea
metastat
solid
cancer
haematolog
malign
underrepres
multivari
analysi
includ
age
sex
initi
sofa
score
comorbid
site
infect
requir
mechan
ventil
lactat
crp
show
initi
low
quintil
adjust
hr
ci
p
high
quintil
adjust
hr
ci
p
nlr
associ
mortal
compar
quintil
nlr
trajectori
first
greater
prognost
valu
initi
measur
alon
patient
persist
low
quintil
minimalno
chang
adjust
hr
ci
p
high
quintil
minimalno
chang
adjust
hr
ci
p
nlr
higher
risk
mortal
prospect
studi
investig
nlr
patient
sepsi
icu
criteria
septic
shock
common
site
infect
lung
intraabdomin
urinari
tract
baselin
nlr
within
admiss
higher
nonsurvivor
n
median
compar
survivor
n
p
roc
analysi
nlr
auc
predict
mortal
compar
baselin
apach
ii
score
nlr
posit
correl
apach
ii
score
baselin
r
p
multivari
analysi
includ
age
apach
ii
apach
ii
score
predict
mortal
ci
nlr
remain
signific
covari
ci
prospect
studi
patient
septic
shock
criteria
examin
nlr
predictor
icu
mortal
includ
stratif
earli
day
late
death
intraabdomin
infect
account
case
nlr
admiss
higher
survivor
n
median
compar
nonsurvivor
n
median
p
nlr
significantli
differ
earli
n
late
n
death
nlr
trajectori
measur
daili
day
evalu
late
death
group
compar
survivor
admiss
nlr
higher
survivor
median
vs
p
revers
day
nlr
lower
survivor
median
vs
p
trajectori
day
show
signific
differ
survivor
compar
late
death
group
p
retrospect
studi
unselect
icu
patient
nlr
icuadmiss
compar
patient
n
without
n
sepsi
criteria
patient
sepsi
higher
baselin
nlr
median
vs
p
retrospect
studi
patient
sever
sepsi
criteria
demonstr
associ
higher
nlr
icu
admiss
subsequ
develop
acut
kidney
injuri
aki
defin
creatinin
mgdl
baselin
increas
creatinin
urin
output
mlkgh
h
mean
nlr
patient
aki
compar
patient
without
p
nlr
remain
independ
covari
multivari
analysi
includ
age
apach
ii
use
ace
inhibitor
angiotensin
receptor
blocker
durat
mechan
ventil
sofa
score
aki
ci
p
higher
admiss
nlr
plr
associ
nosocomi
infect
clinician
diagnos
n
mean
nlr
vs
p
plr
vs
p
retrospect
report
unselect
icu
patient
retrospect
cohort
patient
bacteraemiafungaemia
report
util
sequenti
nlr
measur
marker
mortal
patient
haematolog
malign
hiv
parasit
infect
exclud
escherichia
coli
gram
neg
bacteria
commonli
identifi
n
fungaemia
uncommon
n
nlr
higher
nonsurvivor
day
p
day
becam
appar
day
onward
multivari
analysi
includ
age
sex
charlson
comorbid
index
infect
site
microbiolog
result
higher
nlr
associ
presenc
bacteraemia
studi
see
tabl
fig
vasopressorrequir
nlr
associ
mortal
hr
ci
addit
three
studi
provid
data
associ
nlr
presenc
bacteraemia
critic
ill
patient
sepsi
one
patient
cap
six
report
associ
addit
cohort
tabl
one
studi
includ
patient
sepsi
outwith
icu
five
includ
patient
present
hospit
signssymptom
suggest
infect
across
studi
consist
associ
higher
nlr
presenc
bacteraemia
report
metaanalysi
patient
level
data
perform
use
data
provid
author
five
studi
relat
patient
present
ed
sign
infect
tabl
note
studi
author
provid
patient
level
data
includ
median
nlr
patient
bacteraemia
interquartil
rang
compar
patient
without
p
roc
auc
ci
fig
optimum
nlr
cutoff
determin
youden
j
statist
sensit
specif
j
cutoff
provid
odd
ratio
ci
p
bacteraemia
plr
evalu
cohort
patient
turkey
pcrconfirm
cchf
overal
mortal
patient
plr
n
like
requir
transfus
blood
product
vs
p
higher
mortal
vs
p
use
previous
report
independ
predictor
mortal
thrombocytopenia
prolong
aptt
melaena
somnol
also
perform
well
identifi
patient
risk
mortal
though
two
compar
directli
patient
receiv
ribavirin
exclud
limit
generalis
result
pretreat
nlr
retrospect
investig
predict
prognosi
bell
palsi
bp
n
ramsay
hunt
syndrom
rh
n
bp
often
due
herp
simplex
viru
reactiv
also
caus
varicella
zoster
viru
vzv
rh
caus
vzv
diagnos
base
clinic
find
acuteconvalesc
serolog
higher
baselin
nlr
observ
patient
without
facial
nerv
recoveri
follow
bp
mean
vs
p
electroneurographi
yanagihara
score
sever
score
predict
recoveri
also
associ
associ
observ
rh
nlr
also
report
retrospect
patient
bp
healthi
control
case
classifi
housebrackmann
scale
preand
posttreat
corticosteroid
grade
normal
grade
complet
paralysi
higher
nlr
observ
case
compar
control
mean
vs
p
associ
poorer
recoveri
mean
housebrackmann
score
vs
score
p
lmr
measur
daili
patient
experiment
infect
influenza
n
respiratori
syncyti
viru
rsv
n
human
rhinoviru
hrv
n
experiment
infect
result
symptom
cell
culturepcr
confirm
shed
case
three
virus
symptomat
patient
demonstr
decreas
lmr
respect
asymptomat
patient
trajectori
lmr
declin
recoveri
mirror
symptom
sever
lmr
predict
symptomat
influenzainfect
patient
time
maxim
symptom
day
less
predict
symptomat
rsv
hrv
compar
assess
lmr
patient
ed
requir
hospitalis
diagnos
pcrconfirm
influenza
n
cultureproven
streptococcu
pneumonia
communityacquir
pneumonia
cap
n
found
lmr
associ
influenza
vs
p
final
lmr
evalu
cohort
patient
influenzalik
ill
ili
n
due
pcrconfirm
human
metapneumoviru
coronavirus
hrv
human
parainfluenza
viru
rsv
lmr
found
often
patient
compar
virus
anoth
cohort
patient
ili
present
ed
n
lmr
observ
commonli
patient
posit
influenza
antigen
test
vs
patient
patient
lmr
posit
antigen
test
metaanalysi
patient
level
data
perform
use
data
provid
author
two
studi
relat
patient
symptomat
respiratori
tract
infect
median
lmr
patient
influenza
viru
infect
interquartil
rang
compar
patient
without
p
roc
auc
ci
fig
optimum
lmr
cutoff
determin
youden
j
statist
sensit
specif
j
cutoff
provid
odd
ratio
ci
p
influenza
viru
infect
util
nlr
plr
differenti
acut
heart
failur
ahf
respiratori
tract
infect
rti
investig
retrospect
patient
chronic
heart
failur
chf
hospitalis
due
dyspnoea
patient
exclud
diagnosi
rti
could
made
confid
immunosuppress
nlr
higher
patient
final
diagnosi
rti
vs
p
total
wcc
nlr
measur
ed
studi
prospect
patient
radiologicallyconfirm
cap
nlr
progress
increas
amongst
subgroup
patient
increas
infect
sever
overal
mean
nlr
hospit
admiss
n
icu
admiss
n
inhospit
mortal
n
nlr
also
sequenti
increas
increment
score
nlr
cutoff
associ
p
comorbid
copd
bacteraemia
pneumonia
infect
icu
admiss
inhospit
mortal
nlr
associ
coxiella
burnetii
infect
p
infect
expect
pathogen
infect
compar
pneumonia
due
q
fever
epidem
studi
period
roc
analysi
mortal
show
nlr
auc
superior
neutrophil
count
auc
lymphocyt
count
total
wcc
crp
nlr
independ
associ
outcom
includ
multivari
analysi
age
comorbid
korean
studi
compar
nlr
patient
bacteri
cap
n
mycobacterium
tuberculosi
pulmonari
infect
n
set
intermedi
tb
burden
cap
diagnos
basi
clinic
find
resolut
chest
xray
infiltr
antimicrobi
neg
sputumlavag
fluid
cultur
tuberculosi
neg
viral
pcr
clear
mycobacteri
cultur
perform
respiratori
specimen
pulmonari
tb
diagnos
base
posit
sputumlavag
cultur
adenosin
deaminas
concentr
pleural
fluid
combin
compat
parenchym
lesion
mean
nlr
observ
cap
compar
tb
p
cut
use
sensit
nlr
specif
predict
tb
roc
analysi
nlr
perform
better
crp
nlr
auc
ci
crp
auc
ci
patient
receiv
antimicrobi
admiss
exclud
screen
patient
limit
generalis
result
nlr
assess
retrospect
patient
acidfast
bacillior
cultureposit
pulmonari
tuberculosi
n
biopsyconfirm
sarcoidosi
n
healthi
control
n
patient
receiv
corticosteroid
exclud
nlr
higher
tb
mean
cohort
compar
sarcoidosi
mean
control
mean
cohort
p
admiss
nlr
studi
retrospect
children
bordetella
pertussi
confirm
microbiolog
case
malign
pertussi
diagnos
base
presenc
pneumonia
pulmonari
hypertens
vasopressorrequir
nlr
higher
patient
malign
compar
benign
pertussi
median
vs
p
nlr
predict
malign
pertussi
auc
multivari
model
includ
nlr
total
wcc
cellsl
heart
rate
beatsminut
adjust
odd
ratio
within
model
nlr
ci
compar
ci
total
wcc
util
nlr
predict
dmsa
scan
cortic
lesion
indic
pyelonephr
investig
retrospect
children
year
first
episod
febril
microbiologicallyconfirm
uti
patient
prior
uti
urogenit
abnorm
vesicoureter
reflux
vur
exclud
nlr
higher
patient
cortic
lesion
initi
dmsa
signific
covari
p
follow
logist
regress
includ
age
sex
vur
wcc
crp
similar
studi
children
month
first
episod
microbiologicallyconfirm
febril
uti
n
evalu
dmsa
nlr
higher
patient
cortic
defect
mean
vs
p
preoper
nlr
predictor
postop
sepsi
assess
retrospect
patient
undergo
percutan
nephrolithotomi
patient
develop
postop
infect
organ
commonli
detect
stone
cultur
e
coli
patient
nlr
higher
incid
postop
infect
p
preand
postop
urin
cultur
posit
associ
higher
nlr
p
respect
patient
sever
dental
infect
mostli
submandibular
abscess
requir
surgic
intervent
associ
report
nlr
durat
hospitalis
median
day
vs
day
p
total
dose
antimicrobi
receiv
correl
p
associ
nlr
outcom
diabet
foot
infect
examin
cohort
patient
manag
amput
n
debridementdrainag
n
surgic
intervent
n
nlr
higher
patient
requir
amput
mean
p
compar
requir
debrid
intervent
nlr
higher
patient
went
develop
osteomyel
mean
vs
p
similar
associ
observ
outcom
erythrocyt
sediment
rate
cohort
studi
examin
predict
valu
nlr
radiologicallyconfirm
deep
neck
space
infect
dnsi
children
year
bacteri
tonsil
patient
uncompl
bacteri
tonsil
n
lower
nlr
patient
dnsi
n
median
nlr
vs
p
nlr
plr
examin
retrospect
patient
fournier
gangren
fournier
gangren
diagnos
clinic
patient
fournier
gangren
sever
index
fgsi
score
calcul
admiss
compris
temperatur
heart
rate
respiratori
rate
serum
sodium
serum
potassium
serum
creatinin
serum
bicarbon
haematocrit
total
wcc
patient
divid
underw
singl
debrid
n
compar
underw
multipl
debrid
n
patient
undergo
singl
debrid
lower
nlr
vs
p
plr
vs
p
initi
mean
fgsi
differ
group
case
control
studi
patient
infect
endocard
diagnos
use
modifi
duke
criteria
nlr
examin
predictor
advers
inhospit
outcom
defin
inhospit
mortal
intracerebr
event
cerebrovascular
event
mening
embol
brain
haemorrhag
nlr
higher
patient
neg
outcom
n
mean
compar
n
mean
p
associ
signific
p
multivari
analysi
includ
predictor
advers
outcom
includ
staphylococcu
aureu
infect
end
stage
renal
diseas
requir
surgeri
hazard
ratio
nlr
ci
roc
analysi
show
nlr
better
predictor
advers
outcom
compar
crp
total
wcc
auc
nlr
ci
crp
ci
wcc
ci
nlr
lmr
evalu
casecontrol
studi
differenti
activ
ulcer
coliti
uc
uc
remiss
c
difficil
infect
n
diagnos
detect
toxin
b
pcr
stool
histori
inflammatori
bowel
diseas
healthi
control
without
gastrointestin
diseas
n
although
author
analysi
aim
describ
ratio
context
uc
suffici
data
present
compar
c
difficil
infect
healthi
control
lmr
lower
c
difficil
infect
compar
healthi
control
mean
vs
nlr
higher
mean
vs
three
studi
report
plr
nlr
evalu
helicobact
pylori
infect
plr
increment
higher
patient
symptomat
h
pylori
mean
n
asymptomat
h
pylori
n
healthi
control
n
p
infect
diagnos
urea
breath
test
confirm
gastric
biopsi
similar
studi
use
diagnost
criteria
nlr
higher
patient
h
pylori
infect
n
compar
patient
gastriti
aetiolog
n
vs
p
two
week
success
therapi
resolut
symptom
neg
urea
breath
test
nlr
normalis
howev
clear
therapi
unsuccess
case
trajectori
nlr
case
final
nlr
higher
patient
endoscop
ureas
confirm
h
pylori
peptic
ulcer
n
mean
compar
healthi
control
n
mean
p
nlr
mlr
retrospect
evalu
differenti
malaria
dengu
detect
antigen
iggm
antibodi
patient
thailand
p
vivax
infect
common
p
falciparum
cohort
comparison
dengu
median
nlr
mlr
higher
malaria
nlr
vs
p
mlr
vs
p
neither
nlr
mlr
signific
covari
multivari
analysi
includ
age
gender
nation
haematolog
paramet
total
wcc
neutrophil
count
remain
significantli
differ
lower
dengu
nlr
mlr
report
patient
p
falciparum
p
vivax
malaria
thailand
find
median
nlr
falciparum
vivax
noninfect
control
p
studi
also
report
mlr
falciparum
vivax
control
p
case
import
malaria
netherland
signific
variat
nlr
sever
falciparum
per
guidelin
median
nonsever
falciparum
median
nonfalciparum
median
observ
degre
parasitaemia
correl
nlr
p
anoth
cohort
import
malaria
munich
n
nlr
higher
complic
vs
uncompl
case
median
vs
p
mlr
differ
median
vs
p
peripher
blood
leucocyt
ratio
investig
context
bacteri
infect
includ
bacteraemia
viral
infect
malaria
critic
ill
due
sepsi
consist
associ
report
ten
studi
associ
higher
nlr
presenc
bacteraemia
support
metaanalysi
data
provid
five
studi
tabl
fig
explan
consist
associ
may
nlr
measur
compart
infect
nlr
found
associ
outcom
measur
six
studi
critic
ill
adult
sepsi
direction
associ
consist
like
due
heterogen
sever
level
microbi
aetiolog
site
infect
notwithstand
signific
variat
host
respons
infect
repres
cohort
septic
shock
account
case
furthermor
analysi
strategi
differ
studi
use
quintil
one
studi
compar
continu
variabl
other
quintil
allow
better
differenti
outlier
valu
normal
thu
may
discriminatori
interest
amongst
patient
sepsi
diagnos
septic
shock
high
nlr
associ
mortal
wherea
cohort
compos
patient
septic
shock
revers
observ
previou
work
demonstr
lymphocyt
apoptosi
patient
septic
shock
compar
sepsi
without
shock
lymphocyt
deplet
associ
poorer
outcom
whilst
paradigm
consist
observ
report
appar
paradox
exist
studi
report
convers
neutrophil
deplet
one
possibl
contribut
factor
warrant
investig
highlight
import
highthroughput
clinic
phenotyp
sepsi
syndrom
includ
wide
rang
infecti
aetiolog
heterogen
host
respons
given
evid
report
ubiqu
full
blood
count
data
like
nlr
inform
paramet
compar
total
wcc
neutrophil
count
crp
includ
futur
stratif
model
identifi
sepsi
endotyp
potenti
clinic
util
ratio
also
demonstr
patient
respiratori
tract
infect
febril
uti
children
diabet
foot
infect
respiratori
viru
infect
cchf
tabl
though
prospect
valid
requir
case
consid
respiratori
viru
infect
two
studi
report
associ
lower
lmr
influenza
viru
infect
amongst
adult
respiratori
tract
infect
metaanalysi
fig
ratio
investig
number
cohort
clinic
util
identifi
associ
unclear
opinion
urgent
need
new
biomark
exampl
h
pylori
gastriti
distinguish
pulmonari
tb
sarcoidosi
predict
outcom
bell
palsi
tabl
although
differ
nlr
mlr
identifi
malaria
dengu
found
evid
clinic
util
sinc
total
white
cell
count
remain
better
discrimin
rapid
diagnost
test
exist
organ
absolut
differ
ratio
small
clinic
signific
final
sever
studi
use
outcom
measur
lack
true
clinic
relev
durat
hospitalis
sever
dental
infect
requir
debrid
fournier
gangren
composit
measur
inhospit
mortal
cn
event
endocard
experiment
infect
follow
human
challeng
respiratori
virus
lmr
trajectori
mirror
symptom
sever
cohort
patient
sever
sepsi
septic
shock
nlr
trajectori
first
persist
low
persist
high
better
predictor
mortal
initi
measur
isol
final
patient
bacteraemia
higher
daili
nlr
day
onward
predict
mortal
therefor
longitudin
measur
cours
infect
like
inform
normalis
could
signal
recoveri
thu
contribut
decisionmak
around
antimicrobi
durat
bia
level
patient
select
outcom
report
shown
supplementari
tabl
find
major
studi
replic
valid
prospect
studi
peripher
blood
lymphocyt
count
higher
young
children
consid
interpret
result
studi
conduct
children
pertussi
uti
final
studi
compar
healthi
infect
individu
less
use
stratifi
within
infect
syndrom
overal
identifi
consist
report
associ
nlr
presenc
bacteraemia
clinic
relev
interpret
routin
clinic
data
circumst
presenc
absenc
bacteraemia
relev
clinic
question
prior
result
blood
cultur
result
studi
critic
ill
adult
sepsi
suggest
signal
toward
outcom
may
exist
sophist
patient
stratif
data
analysi
requir
determin
util
identifi
sepsi
endotyp
longitudin
measur
cours
infect
could
inform
hypothesi
requir
test
abil
identifi
influenza
viru
infect
patient
respiratori
tract
infect
use
lmr
potenti
use
valid
gener
investig
ratio
discrimin
bacterialviralparasit
aetiolog
would
valuabl
futur
work
focu
patient
cohort
need
new
biomark
avoid
comparison
infect
healthi
individu
overal
biomark
warrant
recognit
studi
infecti
diseas
